The CNODES network of researchers, trainees, and analysts conduct studies using administrative healthcare data in response to queries from Canadian regulators. The results of these studies are published in open-access academic journals. CNODES also publishes a selection of its methodological advances, knowledge translation initiatives, and trainee projects.

Leong C, Raymond C, Château D, Dahl M, Alessi-Severini S, Falk J, Bugden S, Katz A. Psychotropic drug use before, during, and after pregnancy: a population-based study in a Canadian cohort (2001-2013). Can J Psychiatry. 2017 Aug;62(8):543-550.

Hicks BM, Yin H, Bladou F, Ernst P, Azoulay L. Androgen deprivation therapy for prostate cancer and the risk of hospitalisation for community-acquired pneumonia. Thorax. 2017 Jul;72(7):596-597.

Larivee N, Suissa S, Coulombe J, Tagalakis V, Filion KB. Drospirenone-containing oral contraceptive pills and the risk of venous thromboembolism: an assessment of risk in first-time users and restarters. Drug Saf. 2017 Jul;40(7):583-596

Falk J, Dahl M, Raymond CB, Chateau D, Katz A, Leong C, Bugden S. Opioid use during pregnancy: a population-based cohort study. CMAJ open. 2017 Jun 26;5(2):E517-E523.

Karim ME, Platt RW; BeAMS study group. Estimating inverse probability weights using super learner when weight-model specification is unknown in a marginal structural Cox model context. Stat Med. 2017 Jun 15;36(13):2032-2047.

Shin J, Eberg M, Ernst P, Filion KB. Statin potency and the risk of hospitalization for community-acquired pneumonia: a population-based nested case-control study. Br J Clin Pharmacol. 2017 Jun;83(6):1319-1327.

Christie R, Sketris I, Andreou P, Holbrook A, Levy A. Does the Number of Pharmacies a Patient Frequents Affect Adherence to Statins? J Popul Ther Clin Pharmacol. 2017 May 6;24(2):e20-e50.

Suissa S, Moodie EE, Dell’Aniello S. Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores. Pharmacoepidemiol Drug Saf. 2017 Apr;26(4):459-468.

Secrest M, Udell JA, Filion KB. The cardiovascular safety trials of DPP-4 inhibitors, GLP-1 agonists, and SGLT2 inhibitors. Trends Cardiovasc Med 2017 Apr;27(3):194-202.

Khosrow-Khavar F, Filion KB, Al-Qurashi S, Torabi N, Bouganim N, Suissa S, Azoulay L. Cardiotoxicity of aromatase inhibitors and tamoxifen in post-menopausal women with breast cancer: a systematic review and meta-analysis of randomized controlled trials. Ann Oncol. 2017 Mar 1;28(3):487-496